Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DocMorris AG (DOCM)
DocMorris AG stock price live, this page displays SIX DOCM stock exchange data. View the DOCM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DocMorris AG real time stock price chart below.
What Is the DocMorris AG Stock Price Today?
The DocMorris AG stock price today is 10.26.
What Is the Stock Symbol for DocMorris AG?
The stock symbol for DocMorris AG is "DOCM."
What Stock Exchange Does DocMorris AG Trade On?
DocMorris AG is listed and trades on the Switzerland stock exchange.
Is DocMorris AG a Good Stock to Buy?
Determining whether DocMorris AG, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCM quote. (ISIN: CH0042615283)
What Is the DocMorris AG Stock Price Today?
The DocMorris AG stock price today is 10.26.
What Is the Stock Symbol for DocMorris AG?
The stock symbol for DocMorris AG is "DOCM."
What Stock Exchange Does DocMorris AG Trade On?
DocMorris AG is listed and trades on the Switzerland stock exchange.
Is DocMorris AG a Good Stock to Buy?
Determining whether DocMorris AG, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCM quote. (ISIN: CH0042615283)
10.26
+0.36(+3.64%)
Closed·
Fair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.95
10.37
52 wk Range
3.92
11.25
DOCM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.9510.37
52 wk Range
3.9211.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DOCM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
11.04
Upside
+7.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Zur Rose receives Investment Bank Analyst Rating Update- Investing.com
Pro
Why is DocMorris stock sliding today?- Investing.com
Zur Rose receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
5 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 11.04
(+7.64% Upside)
DocMorris AG Earnings Call Summary for Q2/2026
- DocMorris reported H1 2026 revenue growth of 13.4% in local currency, driven by 38.3% Rx revenue increase and 71% digital services jump.
- Adjusted EBITDA margin improved 350 basis points to -1.8%, though shares fell 6.02% to $9.05 despite raised guidance and strong results.
- Company raised 2026 revenue growth guidance to 9-13% from 3-12%; narrowed expected EBITDA loss to CHF 10-17.5M from CHF 10-25M.
- Management reaffirmed EBITDA breakeven target during 2026; AI-First strategy expected to deliver CHF 50M+ annual savings by end of 2027.
- Key risks include continued cash burn of $114M, negative profitability, and execution uncertainty around co-payment strategy for 2027.
Last Updated: 19/08/2026, 11:22
Read Full TranscriptEarnings
Latest Release
Aug 19, 2026
EPS / Forecast
-1.10 / --
Revenue / Forecast
295.2M / 286.05M
Compare DOCM to Peers and Sector
Metrics to compare | DOCM | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipDOCMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −3.0x | 11.6x | |
PEG Ratio | −0.07 | 0.03 | 0.03 | |
Price/Book | 1.4x | 1.4x | 1.5x | |
Price / LTM Sales | 0.4x | 0.6x | 0.9x | |
Upside (Analyst Target) | 2.9% | 10.5% | 22.4% | |
Fair Value Upside | Unlock | 22.8% | 12.6% | Unlock |
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DocMorris (DOCM) Stock Price Today?
The DocMorris stock price today is 10.26 CHF.
What Stock Exchange Does DocMorris Trade On?
DocMorris is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for DocMorris?
The stock symbol for DocMorris is "DOCM."
What Is the DocMorris Market Cap?
As of today, DocMorris market cap is 518.02M CHF.
What Is DocMorris's Earnings Per Share (TTM)?
The DocMorris EPS (TTM) is -2.61.
When Is the Next DocMorris Earnings Date?
DocMorris will release its next earnings report on Oct 15, 2026.
From a Technical Analysis Perspective, Is DOCM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has DocMorris Stock Split?
DocMorris has split 2 times.
How Many Employees Does DocMorris Have?
DocMorris has 1337 employees.
What is the current trading status of DocMorris (DOCM)?
As of Aug 26, 2026, DocMorris (DOCM) is trading at a price of 10.26 CHF, with a previous close of 9.90 CHF. The stock has fluctuated within a day range of 9.95 CHF to 10.37 CHF, while its 52-week range spans from 3.92 CHF to 11.25 CHF.
What Is DocMorris (DOCM) Price Target According to Analysts?
The average 12-month price target for DocMorris is 11.04 CHF, with a high estimate of 13.6 CHF and a low estimate of 9.5 CHF. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.